Literature DB >> 32483659

Tertiary Lymphoid Organs in Rheumatoid Arthritis.

Felice Rivellese1, Elena Pontarini1, Costantino Pitzalis2.   

Abstract

Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease. RA mainly affects the joints, with inflammation of the synovial membrane, characterized by hyperplasia, neo-angiogenesis, and immune cell infiltration that drives local inflammation and, if untreated, can lead to joint destruction and disability. In parallel to the well-known clinical heterogeneity, the underlying synovitis can also be significantly heterogeneous. In particular, in about 40% of patients with RA, synovitis is characterized by a dense lymphocytic infiltrate that can acquire the features of fully functional tertiary lymphoid organs (TLO). These structures amplify autoimmunity and inflammation locally associated with worse prognosis and potential implications for treatment response. Here, we will review the current knowledge on TLO in RA, with a focus on their pathogenetic and clinical relevance.

Entities:  

Mesh:

Year:  2020        PMID: 32483659     DOI: 10.1007/82_2020_216

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  3 in total

1.  Curcumin alleviates rheumatoid arthritis progression through the phosphatidylinositol 3-kinase/protein kinase B pathway: an in vitro and in vivo study.

Authors:  Zihan Xu; Wei Shang; Zhiming Zhao; Beibei Zhang; Chunli Liu; Hui Cai
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 2.  Synovial single-cell heterogeneity, zonation and interactions: a patchwork of effectors in arthritis.

Authors:  Barbora Schonfeldova; Kristina Zec; Irina A Udalova
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.580

3.  Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome.

Authors:  Estelle Gerossier; Saba Nayar; Mark J Murphy; Marianne M Martinic; Francesca Barone; Sylvie Froidevaux; Charlotte G Smith; Celine Runser; Valentina Iannizzotto; Enrico Vezzali; Gabin Pierlot; Ulrich Mentzel
Journal:  Arthritis Res Ther       Date:  2021-11-29       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.